Amgen to acquire Dark Blue Therapeutics for up to $840M
Amgen to acquire Dark Blue Therapeutics for up to $840M
Amgen to acquire Dark Blue Therapeutics for up to $840M
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page